IDC FutureScape Figure

Figure: IDC FutureScape: Worldwide Life Sciences 2022 Top 10 Predictions

Executive Summary

IDC FutureScape Predictions

Summary of External Drivers

Predictions: Impact on Technology Buyers

Prediction 1: By 2023, 75% of Life Sciences Manufacturers Will Invest in Intelligent Supply Chain Solutions to Enable Resilience and Prevent Future Disruptions During Health Emergencies Such as COVID-19

Associated Drivers

IT Impact

Patient Impact

Guidance

Prediction 2: By 2024, AI Investments in In Silico Drug Discovery Will Double to Fuel Growth of Genomics and Precision Medicine to Bring Vital Vaccines and Medicines to Patients Faster

Associated Drivers

IT Impact

Patient Impact

Guidance

Prediction 3: By 2025, 75% of Trials Will Be Patient-Centric Decentralized Clinical Trials; 90% Will Be Hybrid and at Least 10% Will Be Virtual, Driven by 30% Growth in Connected Health Technologies

Associated Drivers

IT Impact

Patient Impact

Guidance

Prediction 4: By 2025, the Market for Prescription Digital Therapeutics Will More Than Triple, Led by Mental Health and Chronic Conditions, Blurring the Boundaries Between Healthcare and Life Sciences

Associated Drivers

IT Impact

Patient Impact

Guidance

Prediction 5: Investment in AI for Real-World Evidence by Life Sciences Companies Will Double by 2025, Driven by Health Data Interoperability Initiatives and Platforms

Associated Drivers

IT Impact

Patient Impact

Guidance

Prediction 6: By 2026, Two-Thirds of Life Sciences Companies Will Adopt the Intelligent Lab of the Future Leveraging Digital Transformation, Integrating the Internet of Lab Things

Associated Drivers

IT Impact

Patient Impact

Guidance

Prediction 7: By 2026, the Increased Adoption of Medication Adherence Apps, Smart IoT–Based Solutions, and Connected Drug Delivery Systems Will Reduce Treatment Compliance Gaps in Clinical Trials by One-Third

Associated Drivers

IT Impact

Patient Impact

Guidance

Prediction 8: The Use of Digital Twins in Manufacturing and Supply Chain Planning at Multinational Life Sciences Firms Will Double by 2026, with Deeper Adoption in R&D Coming Later

Associated Drivers

IT Impact

Patient Impact

Guidance

Prediction 9: Triggered by COVID-19, Half of New Business Value Created in the Global Life Sciences Market by 2026 Will Be Driven by Cloud-Based Digital Ecosystems and Federated Learning, Powering R&D Co-Innovation

Associated Drivers

IT Impact

Patient Impact

Guidance

Prediction 10: Integrated Research Organizations Will Double in Number by 2027, Fueling the Adoption of Clinical Research as a Care Option Within the Healthcare Ecosystem

Associated Drivers

IT Impact

Patient Impact

Guidance

Advice for Technology Buyers

External Drivers: Detail

Pervasive Disruption Continues — Volatility, Opportunity, and Resilience

Cybersecurity and Risk — The Threat Environment Just Keeps Scaling

The Future Enterprise — Thriving in a Jungle of Agile Innovation

Embracing Digital First — New Strategies for Complexity and Ubiquity

Digital Ecosystem — Thriving in a Multiplatform World

Workforce Outlook — Redefining Teams, Reinventing Models, and Rethinking Leadership

Engagement Reimagined — From Responsive to Anticipatory

Learn More

Related Research